- 【Updated on November 17, 2025】 Integration of CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- CiNii Research researchers search function has been released.
- Regarding the suspension of updates to the "BOOK" database data
Severe COVID-19-related Pneumonia Seven Years after Heart Transplantation
-
- Taniguchi Gentaro
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Matsushima Shouji
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Fujino Takeo
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan Department of Advanced Cardiopulmonary Failure, Graduate School of Medical Sciences, Kyushu University, Japan
-
- Hashimoto Toru
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Shinohara Keisuke
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Kisanuki Hiroshi
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Misumi Kayo
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Katsuki Shunsuke
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
-
- Shiose Akira
- Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kyushu University, Japan
-
- Abe Kohtaro
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Japan
Search this article
Description
<p>A 67-year-old man on intense immunosuppressive therapy after heart transplantation for end-stage hypertrophic cardiomyopathy 7 years ago developed severe dyspnea and was admitted to our hospital. His serum severe acute respiratory syndrome coronavirus 2 antigen test was positive, and he was diagnosed with coronavirus disease 2019 (COVID-19)-related pneumonia. He was started on ventilatory management for severe respiratory failure and remdesivir for COVID-19, with careful adjustment of immunosuppressive drugs. However, unexpectedly prolonged muscle weakness necessitated transfer to a rehabilitation facility. Although the COVID-19 pandemic has subsided, it is still considered a risk in post-transplant cases. Infection control is considered critical in heart transplant recipients, especially in those receiving intensified immunosuppressive drugs. </p>
Journal
-
- Internal Medicine
-
Internal Medicine 64 (12), 1867-1871, 2025-06-15
The Japanese Society of Internal Medicine